WHO launches pathway to improve access to 12 childhood cancer medicines globally
- The World Health Organisation has introduced a new pathway for evaluating childhood cancer medicines.
- The first Expression of Interest includes 12 essential medicines categorised by formulation needs and ongoing supply.
- According to WHO, approximately 400,000 children and adolescents are diagnosed with cancer each year, with survival rates around 30%.
- Manufacturers must submit products for assessment, which will undergo rigorous evaluation before potential inclusion.
Source: ndtv.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
